ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0155

The Additional Value of MRI in Diagnosis of Rheumatoid Arthritis in Undifferentiated Arthritis Patients

Nikolet den Hollander1, Marloes Verstappen1, Navkiran Sidhu1, Elise van Mulligen2, Monique Reijnierse1 and Annette H.M van der Helm-van Mil1, 1Leiden University Medical Center, Leiden, Netherlands, 2Erasmus Medical Center, Rotterdam, Netherlands

Meeting: ACR Convergence 2021

Keywords: Autoantibody(ies), Cohort Study, Magnetic resonance imaging (MRI), rheumatoid arthritis, risk factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Imaging of Rheumatic Diseases Poster (0149–0182)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Identifying patients that will develop rheumatoid arthritis (RA) among those presenting with undifferentiated arthritis (UA) remains a clinical dilemma. According to EULAR recommendations magnetic resonance imaging (MRI) is helpful. An important limitation is that UA is not uniformly characterized. UA is formally defined as not fulfilling RA classification criteria (1987- or 2010-criteria). In clinical practice, rheumatologists identify UA based on clinical expertise. The diagnostic value of MRI has only been determined in UA-patients not fulfilling the 1987-criteria. The data on the value of MRI in UA according to the two common and current definitions is lacking. Therefore, we performed a large study to determine this.

Methods: In total 1234 patients, consecutively included in the Leiden early-arthritis cohort (EAC) between august-2010 and march-2020 underwent MRI-scans of hand and foot, that were scored for erosions, bone marrow edema (BME), synovitis (SYN) and tenosynovitis (TS). Two UA-populations were studied: not fulfilling 1987/2010-criteria and having no other diagnosis (criteria-based UA-population, n=405), and expert-opinion of UA (n=564). Patients were followed up for RA-development (fulfilling 1987/2010-criteria) after 1-year. Logistic regression was used, test characteristics and predictive values were determined, also in clinically-relevant subgroups.

Results: Within criteria-based UA-patients, 21% developed RA. Except for BME, all MRI-features were prognostic for RA-development. Only MRI-TS was independently associated with RA-development (OR 2.79, 95% CI: 1.40-5.58), especially within ACPA-negative UA-patients (OR 2.91; 1.42-5.96). Particularly within the oligoarthritis-subgroup, MRI-TS was predictive for RA-development (NPV 93%; PPV 28%; sensitivity 85%; specificity 45%). Compared with oligo-/polyarthritis alone, MRI-TS improved prediction of RA-development within the oligoarthritis-subgroup (Net Reclassification Index 0.28). Similar results were found in the expert opinion UA-population.

Conclusion: This large cohort study showed MRI has additional prognostic value for early identification of RA. The value was highest within ACPA-negative UA-patients with oligoarthritis. Although cost-effectiveness remains to be determined, this shows MRI is useful for early recognition of RA in subgroups of UA-patients.


Disclosures: N. den Hollander, None; M. Verstappen, None; N. Sidhu, None; E. van Mulligen, None; M. Reijnierse, None; A. van der Helm-van Mil, None.

To cite this abstract in AMA style:

den Hollander N, Verstappen M, Sidhu N, van Mulligen E, Reijnierse M, van der Helm-van Mil A. The Additional Value of MRI in Diagnosis of Rheumatoid Arthritis in Undifferentiated Arthritis Patients [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/the-additional-value-of-mri-in-diagnosis-of-rheumatoid-arthritis-in-undifferentiated-arthritis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-additional-value-of-mri-in-diagnosis-of-rheumatoid-arthritis-in-undifferentiated-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology